Combination of antidepressants in the treatment of major depressive disorder: A systematic review and meta-analysis

Journal of Clinical Psychopharmacology

Volumn 32, Issue 2, 2012, Pages 278-281

  Rocha, Fábio Lopes ^a   Fuzikawa, Cíntia ^b   Riera, Rachel ^c   Hara, Cláudia ^d  

^a Instituto de Previdencia Dos Servidores do Estado de Minas Gerais IPSEMG   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d Faculdade da Saúde e Ecologia Humana FASEH Vespasiano   (Brazil)

Author keywords

Antidepressant agents; Combination drug therapy; Major depressive disorder

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; DESIPRAMINE; FLUOXETINE; MIANSERIN; MIRTAZAPINE; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

COCHRANE LIBRARY; COMBINATION CHEMOTHERAPY; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG TOLERABILITY; EMBASE; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MEDLINE; META ANALYSIS; MONOTHERAPY; MONTGOMERY ASBERG DEPRESSION RATING SCALE; ORTHOSTATIC HYPOTENSION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCINFO; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REVIEW; SYSTEMATIC REVIEW; TACHYCARDIA; TREATMENT RESPONSE;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMISSION INDUCTION; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 84857838800     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318248581b     Document Type: Review

References (16)

1. Organization WH. The Global Burden of Disease: 2004 update. Geneva, Switzerland: World Health Organization; 2008.
2. Smith D, Dempster C, Glanville J, et al. Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis. Br J Psychiatry. 2002;180(5):396-404. (Pubitemid 34499333)
3. Casacalenda N, Perry JC, Looper K. Remission in major depressive disorder: a comparison of pharmacotherapy, psychotherapy, and control conditions. Am J Psychiatry. 2002;159(8):1354-1360. (Pubitemid 34832717)
4. Pigott HE, Leventhal AM, Alter GS, et al. Efficacy and effectiveness of antidepressants: current status of research. Psychother Psychosom. 2010;79(5):267-279.
5. Rush AJ. Combining antidepressant medications: a good idea? Am J Psychiatry. 2010;167(3):241-243.
6. El-Mallakh RS, Kaur G, Lippman S. Placebo group needed for interpretation of combination trial. Am J Psychiatry. 2010;167(8):996.
7. Dodd S, Horgan D, Malhi GS, et al. To combine or not to combine? A literature review of antidepressant combination therapy. J Affect Disord. 2005;89(1-3):1-11. (Pubitemid 41740829)
8. Keller MB. Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond. JAMA. 2003;289(23):3152-3160. (Pubitemid 37432891)
9. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Chichester: John Wiley & Sons Ltd.; 2008.
10. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMI. 2003;327(7414):557-560. (Pubitemid 37088507)
11. Blier P, Gobbi G, Turcotte JE, et al. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation. Eur Neuropsychopharmacol. 2009;19(7):457-465.
12. Blier P, Ward HE, Tremblay P, et al. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study. Am J Psychiatry. 2010;167(3):281-288.
13. Dam J, Ryde L, Svejso J, et al. Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression. Pharmacopsychiatry. 1998;31(2):48-54. (Pubitemid 28150203)
14. Raisi F, Habibi N, Nasehi AA, et al. Combination of citalopram and nortriptyline in treatment of severe major depression: a double-blind, placebo-controlled trial. Therapy. 2007;4(2): 187-192. (Pubitemid 46488159)
15. Nelson JC, Mazure CM, Jatlow PI, et al. Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study. Biol Psychiatry. 2004;55(3):296-300. (Pubitemid 38117167)
16. Demyttenaere K, Jaspers L. Review: bupropion and SSRI-induced side effects. J Psychopharmacol. 2008;22(7):792-804.